Global Dealer Solutions Highlights the Growing Importance of Auto Dealer Local Search Marketing

COPPELL, TX, Dec. 03, 2025 (GLOBE NEWSWIRE) — COPPELL, TX – December 04, 2025 – – Global Dealer Solutions (GDS) today announced a renewed focus on the critical role Local SEO now plays in helping automotive dealerships appear where customers are most likely to search: Google Search, Google Maps, and “near me” results. As consumer […]

Global Dealer Solutions Highlights the Growing Importance of Auto Dealer Local Search Marketing

Global Dealer Solutions Highlights the Growing Importance of Auto Dealer Local Search Marketing GlobeNewswire December 04, 2025 COPPELL, TX, Dec. 03, 2025 (GLOBE NEWSWIRE) — COPPELL, TX – December 04, 2025 – – Global Dealer Solutions (GDS) today announced a renewed focus on the critical role Local SEO now plays in helping automotive dealerships appear

Renewal of Notice of Intention to Distribute Securities and Amended Early Warning Report

Vancouver, British Columbia–(Newsfile Corp. – December 3, 2025) – Coenda Investments Holding Corp. (“Coenda“), a company controlled by Kerem Akbas, announces that it has renewed its previously filed notice of intention to divest its holdings in INEO Tech Corp. (TSXV: INEO) (OTCQB: INEOF) (“INEO” or the “Issuer“) and has filed an amended early warning report

CYMAT ANNOUNCES RECEIPT OF $1.8M ORDER OF UNDERBELLY KITS FOR ASIAN MILITARY

Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the “Company” or “Cymat”) is pleased to announce that SmartMetal™, a division of Cymat, has received its next serial production order to provide stabilized aluminum foam underbelly kits to an Asian military vehicle manufacturer. This purchase order consists of 176 blast-protection kits with an order value of $1.8

Lear Investment Management Earns PSN Top Guns Awards for its Global Vigilance, GV Tilt and GV Conservative Strategies

Best performing strategies for Q3 2025 quarter PSN Top Guns List published by Zephyr identifies best-in-class separate accounts, managed accounts, and managed ETF strategies. Lear Investment Management, a Dallas based investment firm, announced today the inclusion of three SMA strategies onto the influential PSN Top Guns Listof best performing separate accounts, managed accounts, and managed

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB

New York, New York–(Newsfile Corp. – December 3, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or traceable to the Registration Statement issued in connection with StubHub’s September 2025 initial public offering (the “IPO”), of the important January 23, 2026

Sankamap Updates Status on Late Filing of Financial Statements; Extends MCTO

Edmonton, Alberta–(Newsfile Corp. – December 3, 2025) – Sankamap Metals Inc. (CSE: SCU) (“Sankamap” or the “Company“) further to the Company’s news releases dated October 21, 2025, November 4, 2025, and November 18, 2025, the Company continues to work towards the filing of its annual audited financial statements and management’s discussion and analysis for the

NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO

(NasdaqGM:NBP), Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistance The Phase 1 ragistomig study achieved its objective, as the new Q6W extended dosing interval produced strong anti-tumor efficacy in PD-L1-non-responders, with an improved safety

NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO

NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO GlobeNewswire December 04, 2025 Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistance The Phase 1 ragistomig study achieved its objective, as the new

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

(NYSE:RGNT), Herzliya, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) — Regentis Biomaterials Ltd. (NYSE American: RGNT) (“Regentis”, or the “Company”), a regenerative medicine company dedicated to developing innovative tissue repair solutions that seek to restore the health and enhance the quality of life of patients, today announced the pricing of its initial public offering (the “Offering”)

Scroll to Top